Pazopanib Teva 200 mg filmom obložene tablete
| Name | Pazopanib Teva 200 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-259497647 |
| Active Substance | pazopanibklorid |
| Composition | jedna filmom obložena tableta sadrži 200 mg pazopaniba u obliku pazopanibklorida |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | PharOS MT Ltd, Birzebbugia, Malta
Remedica Ltd., Limassol, Cipar |
| Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
| Marketing Authorisation Date | 03.01.2022 |
| MA Period of Validity | 03.01.2027 |
| Classification Number | UP/I-530-09/21-01/147 |
| Registration Number | 381-12-01/70-22-04 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01EX03 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
